Editorial: Combined modality treatment of resectable and borderline resectable pancreas cancer: Expert consensus conference

Annals of Surgical Oncology

Volumn 16, Issue 7, 2009, Pages 1757-1759

  Berlin, Jordan ^a   Hoffman, John P ^b   Regine, William F ^c  

^a VANDERBILT INGRAM CANCER CENTER   (United States)

^b FOX CHASE CANCER CENTER   (United States)

^c UNIVERSITY OF MARYLAND MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ERLOTINIB; FLUOROURACIL; GEMCITABINE;

ADD ON THERAPY; ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL TRIAL; COMPARATIVE STUDY; COMPUTER ASSISTED TOMOGRAPHY; EDITORIAL; ENDOSCOPIC ECHOGRAPHY; HUMAN; METASTASIS; MORBIDITY; MULTIMODALITY CANCER THERAPY; OVERALL SURVIVAL; PANCREAS CANCER; POSTOPERATIVE CARE;

COMBINED MODALITY THERAPY; HUMANS; PANCREATIC NEOPLASMS;

EID: 67649158718     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-009-0412-x     Document Type: Editorial

References (7)

1. Abrams, RA, Lowy AM, O'Reilly EM, Wolff RA, Picozzi VJ, Pisters PWT. Combined modality treatment of resectable and borderline resectable pancreas cancer: Expert consensus statement. Ann Surg Oncol. 2009; [Epub ahead of print]. DOI:10.1245/ s10434-009-0413-9.
2. Neoptolemos J P,Stocken DD, Friess H, Bassi C, Dunn JA, Hickey H, et al. A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer. N Engl J Med. 2004;350:1200-10.
3. Oettle H, Post S, Neuhaus P, Gellert K, Langrehr J, Ridwelski K, et al. Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial. JAMA. 2007;297:267-77.
4. Moore MJ, Goldstein D, Hamm J, Figer A, Hecht JR, Gallinger S, et al.: Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol. 2007;25:1960-6.
5. Regine WF, Winter KA, Abrams RA, Safran H, Hoffman JP, Konski A, et al. Fluorouracil vs gemcitabine chemotherapy before and after fluorouracil-based chemoradiation following resection of pancreatic adenocarcinoma: a randomized controlled trial. JAMA. 2008;299:1019-26.
6. Abrams RA, Winter KA, Regine WF, Safran H, Hoffman JP, Konski AA, et al. RTOG 97-04-Radiotherapy Quality Assurance (QA) Review and Survival. Proceedings of ASTRO, Int J Radiat Oncol Biol Phys. 2006;66:S22.
7. Lieberman MD, Kilburn H, Lindsey M, Brennan MF. Relation of perioperative deaths to hospital volume among patients undergoing pancreatic resection for malignancy. Ann Surg. 1995;225:638-45.